Table 3 Prior authorization request outcome by payer type and test category.
Prior authorization request approved or prior authorization not required (n = 3,627) | Prior authorization request denied (n = 908) | p valueb | |
|---|---|---|---|
Overalla | |||
Private | 1,154 (70.3%) | 488 (29.7%) | <0.001 |
Public | 2,473 (85.5%) | 420 (14.5%) | |
By test category | |||
Cytogenetic and molecular | |||
Private | 596 (80.5%) | 144 (19.5%) | <0.001 |
Public | 1,414 (95.3%) | 70 (4.7%) | |
Epigenetic | |||
Private | 21 (72.4%) | 8 (27.6%) | 0.043 |
Public | 51 (89.5%) | 6 (10.5%) | |
Exome | |||
Private | 240 (63.2%) | 140 (36.8%) | 0.009 |
Public | 283 (72.0%) | 110 (28.0%) | |
Mitochondrial | |||
Private | 6 (35.3%) | 11 (64.7%) | 0.086 |
Public | 15 (62.5%) | 9 (37.5%) | |
Single-gene and multigene panel | |||
Private | 291 (61.1%) | 185 (38.9%) | <0.001 |
Public | 710 (75.9%) | 225 (24.1%) | |
